AFP and liver cancer: However, due to its insidious nature, most patients are diagnosed at the middle to advanced stages, resulting in poor treatment outcomes and a 5-year survival rate below 20%.[63] In clinical practice, alpha-fetoprotein is a widely used tumor marker for diagnosing liver cancer.